Thomas et al. [33] have reported that antibody–drug conjugate (anti-TIM-1 antibody covalently linked to monomethyl auristatin E) has significant anti-tumor effect on TIM-1-expressing tumors both in vitro and in vivo, including lung cancer. Here, HAVCR1 is linked to neoplasm.